Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study
NCT02092779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 447
Last updated 2014-03-20
Summary
Obesity is a disease not always attributable to nutritional imbalance, frequently associated with changes in key hypothalamic-pituitary (HP) axes. The regain of weight loss after hypochaloric diets has been ascribed to these HP disregulations. The aim of the study is to explore pituitary morphology and its association with pituitary function and metabolic phenotype in outpatient obese individuals evaluated in the period 2010-2013 at the Department of Experimental Medicine of the University of Rome La Sapienza, with features of HP disease in a cross-sectional .
Conditions
Sponsors & Collaborators
-
University of Roma La Sapienza
lead OTHER
Principal Investigators
-
Lucio Gnessi, MD, PhD · University of Roma La Sapienza
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
More Related Trials
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
NCT00921609 ·Status: COMPLETED
-
Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype
NCT01616095 ·Status: COMPLETED
-
Lipolytic Effects of GH in Hypopituitary Patients in Vivo
NCT02782208 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone as a Determinant of Weight Regulation
NCT00355784 ·Status: COMPLETED ·Phase: NA
-
Muscle in Acromegaly and Cushing's Syndrome
NCT03673761 ·Status: UNKNOWN
-
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
NCT03225755 ·Status: COMPLETED
-
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
NCT01421589 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone and Heart Failure
NCT00190359 ·Status: TERMINATED
-
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
NCT00591760 ·Status: COMPLETED ·Phase: PHASE2
-
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
NCT06344650 ·Status: RECRUITING
-
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
NCT02092129 ·Status: UNKNOWN
-
Lipolytic Effects of GH in Human Subjects in Vivo
NCT02782221 ·Status: COMPLETED ·Phase: NA
-
Effects of GH and Lirglutide on AgRP
NCT05681299 ·Status: RECRUITING ·Phase: PHASE4
-
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
NCT00131378 ·Status: COMPLETED ·Phase: NA
-
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
NCT01007071 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Pasireotide Lar Therapy on Bone Metabolism
NCT07179926 ·Status: RECRUITING
-
Growth Hormone Evaluation in the Elderly People
NCT02240043 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
NCT00915954 ·Status: COMPLETED ·Phase: NA
-
Acylated Ghrelin Response to Acute Exercise in Obesity
NCT00486161 ·Status: COMPLETED
-
Mechanism of Growth Hormone Effects on Adipose Tissue
NCT00453557 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
NCT01302652 ·Status: COMPLETED
-
Gene Expression in Monocytes of Growth Hormone Deficient Children
NCT04352712 ·Status: UNKNOWN
-
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945 ·Status: COMPLETED ·Phase: NA
-
Effect of Respiratory Training Protocols on GH Secretion in Obesity (ALRESPGHOB)
NCT05759598 ·Status: TERMINATED ·Phase: NA